Unternehmen ONECHAIN IMMUNOTHERAPEUTICS S.L. ONECHAIN IMMUNOTHERAPEUTICS S.L. – Unternehmen mit Aktivitäten in Forschung und Innovation. ONECHAIN IMMUNOTHERAPEUTICS S.L. Passend zu diesem Beitrag Forschungsprojekte 3 Verknüpfungen Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia Acute Myeloid Leukemia (AML) results from the uncontrolled expansion of differentiation-defective hematopoiet… → Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-cell acute lymphoblastic leukemia R/R T-ALL remains a major clinical challenge. Despite improved survival rates thanks to intensive chemotherap… → Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches The human immune system controls the efficiency to respond to infections and eliminate aberrant cells, such a… →